Hypofractionated Versus Standard Fractionated Whole Breast Irradiation to Node-negative Breast Cancer Patients

NCT00909818 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 976

Last updated 2021-08-24

No results posted yet for this study

Summary

The purpose of this study is to investigate the difference in late radiation morbidity between hypofractionated and standard fractionated breast irradiation given to women operated with breast conservation for early breast cancer.

Conditions

Interventions

RADIATION

standard fractionated radiotherapy

standard fractionated radiotherapy 50 Gy/25 fractions

RADIATION

hypofractionated radiotherapy

hypofractionated radiotherapy 40 Gy/15 fractions

Sponsors & Collaborators

  • Danish Cancer Society

    collaborator OTHER
  • Danish Breast Cancer Cooperative Group

    lead OTHER

Principal Investigators

  • Lars Stenbygaard, MD · Aalborg University Hospital

  • Birgitte Offersen, MD, Ph.D · Aarhus University Hospital

  • Erik Jakobsen, MD · Vejle Hospital

  • Mette H Nielsen, MD, phd · Odense University Hospital

  • Birgitte Offersen, MD, phd · Aarhus University Hospital

  • Mechthild Krause, M.D., Prof · University Clinic Carl Gustav Carus Dresden

  • Andreas Schreiber, M.D., Ph.D. · Praxis für Strahlentherapie am Klinikum Dresden-Friedrichstadt

  • Ingvil Mjaaland, M.D. · Helse Stavanger HF, Sorlandet Sykehus HF

  • Unn-Miriam Kasti, M.D. · Kristiansand Sykehus

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
41 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-14
Primary Completion
2024-05-31
Completion
2024-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00909818 on ClinicalTrials.gov